Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | PLA2G6 | O60733 | 3/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL241233 | 0.83 | NPSR1 (0.34) | CYP2C9CYP3A4POLBALDH1A1NPSR1 | |
| SCHEMBL241465 | 0.76 | NPSR1 (0.38) | CYP2C19CYP3A4POLBALDH1A1NPSR1 | |
| SCHEMBL242551 | 0.74 | TOP1 (0.43) | CYP2C9CYP2C19CYP1A2CYP2D6HIF1A | |
| SCHEMBL28905026 | 0.73 | AR (0.42) | CYP2C9CYP2C19CYP1A2CYP2D6HIF1A | |
| SCHEMBL241702 | 0.72 | CYP1A2 (0.38) | CYP2C9CYP2C19CYP1A2CYP2D6HIF1A | |
| SCHEMBL242059 | 0.71 | NPSR1 (0.31) | MTNR1AIDO1NPSR1 | |
| SCHEMBL9422307 | 0.69 | POLB (0.47) | CYP2C9CYP2C19CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL29644308 | 0.69 | POLB (0.47) | CYP2C9CYP2C19CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL14339295 | 0.67 | LMNA (0.46) | CYP2C9CYP2C19CYP1A2CYP2D6CYP3A4 | |
| SCHEMBL14339276 | 0.66 | LMNA (0.45) | CYP2C9CYP2C19CYP1A2CYP2D6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2076524-B1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2016-04-20 | — | — | EP | disclosed |
| EP-2076524-B1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2016-04-20 | — | — | EP | disclosed |
| US-8735583-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) | 2014-05-27 | — | — | US | disclosed |
| US-8735583-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED CO. (GB) | 2014-05-27 | — | — | US | disclosed |
| US-20130150583-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-06-13 | — | — | US | disclosed |
| US-20130150583-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-06-13 | — | — | US | disclosed |
| US-8404843-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-03-26 | — | — | US | disclosed |
| US-8404843-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2013-03-26 | — | — | US | disclosed |
| US-20120264940-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-10-18 | — | — | US | disclosed |
| US-20120264940-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-10-18 | — | — | US | disclosed |
| US-8222415-B2 | Chiral phosphorus compound | JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) | 2012-07-17 | — | — | US | disclosed |
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2012-01-05 | — | — | US | disclosed |
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2012-01-05 | — | — | US | disclosed |
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2012-01-05 | — | — | US | disclosed |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2010-09-23 | — | — | US | disclosed |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2010-09-23 | — | — | US | disclosed |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2010-09-23 | — | — | US | disclosed |
| EP-2076524-A1 | CHIRAL PHOSPHORUS COMPOUND | Johnson Matthey Public Limited Company (GB) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008041029-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2008-04-10 | — | — | WO | disclosed |
| WO-2008041029-A1 | CHIRAL PHOSPHORUS COMPOUND | JOHNSON MATTHEY PLC (GB) | 2008-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264940-A1 | CHIRAL PHOSPHORUS COMPOUND | PIK3CA, RECQL, P2RY1 | CYP2C9 1355/4885CYP2C19 1040/4885CYP1A2 915/4885 |
| US-20120004411-A9 | CHIRAL PHOSPHORUS COMPOUND | PIK3CA, RECQL, P2RY1 | CYP2C9 1355/4885CYP2C19 1040/4885CYP1A2 915/4885 |
| US-20100240898-A1 | CHIRAL PHOSPHORUS COMPOUND | PIK3CA, RECQL, P2RY1 | CYP2C9 1355/4885CYP2C19 1040/4885CYP1A2 915/4885 |
| US-20130150583-A1 | CHIRAL PHOSPHORUS COMPOUND | ALPP, PTH1R, CALCR | CYP2C9 2011/4885CYP2C19 2159/4885CYP1A2 2271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.